<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang M</submitter><funding>Natural Science Foundation of Shandong Province (Shandong Provincial Natural Science Foundation)</funding><funding>Natural Science Foundation of Shandong Province</funding><funding>National Natural Science Foundation of China</funding><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>3858</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12022087</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>The neural substrates of anxiety are poorly understood, which hinders treatment of anxiety disorders. Here we found, αCaMKII&lt;sup>+&lt;/sup> neurons in the ventral medial hypothalamic nucleus (VMH) responded to stressors with increased activity in male mice, both under physiological conditions and after repeated restraint stress. Activation of VMH αCaMKII&lt;sup>+&lt;/sup> neurons were necessary and sufficient to ameliorate stress-induced anxiety. The peripheral metabolic hormone ghrelin and receptor GHS-R1a play a complex role in emotion regulation; however, the mechanism is uncertain. A delayed increase in GHS-R1a expression in VMH αCaMKII&lt;sup>+&lt;/sup> neurons coincided with the development of stress-induced enhancement of anxiety-related behavior. GHS-R1a expression in VMH αCaMKII&lt;sup>+&lt;/sup> neur</pubmed_abstract><journal>Nature communications</journal><pubmed_title>GHS-R1a signaling drives anxiety-related behavior by shaping excitability of ventromedial hypothalamic neurons.</pubmed_title><pmcid>PMC12022087</pmcid><funding_grant_id>ZR2019ZD34</funding_grant_id><funding_grant_id>91732110</funding_grant_id><funding_grant_id>32071141</funding_grant_id><funding_grant_id>32371211</funding_grant_id><pubmed_authors>Yang J</pubmed_authors><pubmed_authors>Yu M</pubmed_authors><pubmed_authors>Yang L</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Lu Y</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Zhang M</pubmed_authors><pubmed_authors>Sun X</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Yu H</pubmed_authors><pubmed_authors>Li N</pubmed_authors><pubmed_authors>Mi X</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Hu G</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Niu M</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>GHS-R1a signaling drives anxiety-related behavior by shaping excitability of ventromedial hypothalamic neurons.</name><description>The neural substrates of anxiety are poorly understood, which hinders treatment of anxiety disorders. Here we found, αCaMKII&lt;sup>+&lt;/sup> neurons in the ventral medial hypothalamic nucleus (VMH) responded to stressors with increased activity in male mice, both under physiological conditions and after repeated restraint stress. Activation of VMH αCaMKII&lt;sup>+&lt;/sup> neurons were necessary and sufficient to ameliorate stress-induced anxiety. The peripheral metabolic hormone ghrelin and receptor GHS-R1a play a complex role in emotion regulation; however, the mechanism is uncertain. A delayed increase in GHS-R1a expression in VMH αCaMKII&lt;sup>+&lt;/sup> neurons coincided with the development of stress-induced enhancement of anxiety-related behavior. GHS-R1a expression in VMH αCaMKII&lt;sup>+&lt;/sup> neur</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2025-07-01T03:05:48.554Z</modification><creation>2025-07-01T03:05:48.554Z</creation></dates><accession>S-EPMC12022087</accession><cross_references><pubmed>40274845</pubmed><doi>10.1038/s41467-025-59116-3</doi></cross_references></HashMap>